Business
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)
THE WOODLANDS, TX, April 03, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced an abstract detailing its technology and early proof-of-concept study results has been accepted for poster presentation at the 2025 European Conference on Interventional Oncology (ECIO), being held April 13-16, 2025 in Rotterdam, Netherlands. Details of the poster presentatio
About this update from Autonomix Medical, Inc.
[{"type":"image","alt":"Autonomix Medical, Inc.","displaySize":"","headline":null,"caption":"Autonomix Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":174,"url":"https://media.zenfs.com/en/globenewswire.com/5cca67be9740fed2b1f7fe47e0e265b6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yXZC_k658ygjAcliUe7Yow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI0NDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5cca67be9740fed2b1f7fe47e0e265b6","width":300,"height":174}},"lazy":false},{"type":"text","content":"THE WOODLANDS, TX, April 03, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced an abstract detailing its technology and early proof-of-concept study results has been accepted for poster presentation at the 2025 European Conference on Interventional Oncology (ECIO), being held April 13-16, 2025 in Rotterdam, Netherlands.","length":471,"tagName":"p"},{"type":"text","content":"Details of the poster presentation are as follows:","length":50,"tagName":"p"},{"type":"text","content":"Title: Catheter-Based Transvascular RF Neural Ablation for Severe Pancreatic Cancer Pain: First Results from The Elpis Study Authors: Robert S. Schwartz, MD, Chief Medical Officer of Autonomix Medical, Inc, and Askar Uktamovich Sabirov, MD, Primary Investigator, AKFA Medline Hospital","length":295,"tagName":"p"},{"type":"text","content":"About ECIO 2025","length":15,"tagName":"p"},{"type":"text","content":"The European Conference on Interventional Oncology (ECIO) is renowned as the most comprehensive platform for interventional oncology education and knowledge sharing - bringing together a growing community of experts from around the world for a multidisciplinary program covering all aspects of Interventional Oncology (IO). The conference will feature an outstanding line-up of more than 140 lectures and 16 hands-on training sessions, which will include highlights on topics such as immuno-oncology, revolutions in HCC treatment, pediatric IO, and much more.","length":559,"tagName":"p"},{"type":"text","content":"For more information about the ECIO 2025 please visit the conference website.","length":82,"tagName":"p"},{"type":"text","content":"About Autonomix Medical, Inc...